Gastroenterology and Hepatology

Episodes 1-16 of 50

• • 

    

    Anthony J. Lembo, MD

    Peer

  11

  

  RestartResume

  IBS-D: A Case Study Approach to Improved Screening and Detection

• • 

    

    Bincy P. Abraham, MD, MS

    Peer

  • 

    

    Jason Ken Hou, MD, MS, FACG

    Peer

  • 

    

    Siddharth Singh, MD

    Peer

  11

  

  RestartResume

  Iron Deficiency Anemia in Patients with Inflammatory Bowel Disease

• • 

    

    Jeffrey B. Danzig, MD

    Peer

  11

  

  RestartResume

  IBS-D: The Role of Pathophysiology in Assessment and Treatment

• • 

    

    Darren M. Brenner, MD, AGAF

    Peer

  9

  

  RestartResume

  IBS-D: What to Do When Typical Treatment Methods Fail

• • 

    

    Vincent A. Mukkada, MD

    Peer

  13

  

  RestartResume

  Eosinophilic Esophagitis: Nutritional Considerations in Pediatric Management

• • 

    

    Adam S. Cheifetz, MD

    Peer

  • 

    

    Alan C. Moss, MD

    Peer

  6

  

  RestartResume

  New Directions on Therapeutic Drug Monitoring in IBD

• • 

    

    Benjamin A. Weinberg, MD

    Peer

  1

  

  RestartResume

  Unraveling Disease Progression Predictors of mCRC

• • 

    

    Benjamin A. Weinberg, MD

    Peer

  1

  

  RestartResume

  Right-Left Divide: Prognostic Importance of Tumor Sidedness

• • 

    

    Benjamin A. Weinberg, MD

    Peer

  1

  

  RestartResume

  NCCN Guidelines on mCRC in an Era of Tumor Sidedness

• • 

    

    Benjamin A. Weinberg, MD

    Peer

  1

  

  RestartResume

  Expanding NCCN Guidelines for mCRC Care

• • 

    

    Edmond Bendaly, MD, FACP

    Peer

  14

  

  RestartResume

  The Standouts: One Colorectal Cancer Patient’s Story

• • 

    

    Richard Kim, MD

    Peer

  2

  

  RestartResume

  What is the Role of KRAS Testing in Therapeutic Decision Making for mCRC?

• • 

    

    Richard Kim, MD

    Peer

  3

  

  RestartResume

  mCRC Case Review: How to Make Informed Decisions for Personalized Treatment

• • 

    

    Shira Johnson, MD

    Peer

  • 

    

    Edmond Bendaly, MD, FACP

    Peer

  16

  

  RestartResume

  The Role of Targeted Therapy in Metastatic Colorectal Cancer Patient Care

• • 

    

    Richard Kim, MD

    Peer

  2

  

  RestartResume

  How mCRC Tumor Sidedness Guides Treatment Decisions

• • 

    

    Allan Gibofsky, MD, JD, MACR, FACP, FCLM

    Peer

  • 

    

    Bruce E. Sands, MD, MS

    Peer

  13

  

  RestartResume

  JAK-STAT Signaling and Disease Pathogenesis in RA and IBD

• Prev
• 1
• 2
• 3
• 4
• Next